Nevro obtains new expanded MR-conditional labeling for Senza SCS system

Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received CE Mark for expanded MR-conditional labeling.



from The Medical News http://ift.tt/1zi0xjo